(Q44444547)

3 December 2017

Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients (English)

1 reference

3 December 2017

Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo‐Asian patients (English)

1 reference

https://api.crossref.org/works/10.1046/J.1464-5491.2003.00925.X

3 January 2024

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1464-5491.2003.00925.X

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1464-5491.2003.00925.X

3 January 2024

author name string

Indo-Asian Trial Investigators

8

1 reference

3 December 2017

A. H. Barnett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752488

3 January 2024

P. J. Grant

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752488

3 January 2024

G. A. Hitman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752488

3 January 2024

H. Mather

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752488

3 January 2024

M. Pawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752488

3 January 2024

L. Robertson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752488

3 January 2024

A. Trelfa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752488

3 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12752488

3 January 2024

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1464-5491.2003.00925.x

1 reference

https://api.crossref.org/works/10.1046/J.1464-5491.2003.00925.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1464-5491.2003.00925.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1464-5491.2003.00925.X

3 January 2024

1 reference

3 December 2017

20

1 reference

3 December 2017

387-393

1 reference

3 December 2017

5

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

3 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Diabetes in British south Asians: nature, nurture, and culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Comparative prevalence of non-insulin-dependent diabetes mellitus in Asian and white Caucasian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Mortality from coronary heart disease in Asian communities in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Variation in the progression of diabetic nephropathy according to racial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Ethnicity and risk factors for coronary heart disease in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Rosiglitazone monotherapy is effective in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Central role of the adipocyte in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Fatty acids, lipotoxicity and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Ethnicity and type 2 diabetes: focus on Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00925.X

The Coventry Diabetes Study: Prevalence of Diabetes and Impaired Glucose Tolerance in Europids and Asians

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1464-5491.2003.00925.X

Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus

3 January 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1464-5491.2003.00925.X

Troglitazone has no effect on red cell mass or other erythropoietic parameters

3 January 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1464-5491.2003.00925.X

3 January 2024

Identifiers

1 reference

3 December 2017

1 reference